COVID-19 Lessons: Experts Predict Shift Toward Intermittent Hemodialysis In ICUs
The pandemic may accelerate a move toward versatile, single-solution renal replacement therapy in intensive care.
You may also be interested in...
The US Medicare agency introduced a new end-stage renal disease treatment model on Friday to incentivize use of home dialysis.
Demand for Baxter's acute therapy products helped offset declines across its advanced surgery, pharmaceuticals and medication-delivery businesses in the second quarter.
The de novo clearance makes the Carpediem system the first commercially available system indicated for continuous renal replacement therapy in pediatric patients.